低分子API(医薬原体)の世界市場動向および予測:合成/化学API、生物学的API

Market Research Futureが発行した調査報告書(DATA611024)
◆英語タイトル:Global Small Molecule API Market Development and Demand Research Report- Forecast to 2027
◆商品コード:DATA611024
◆発行会社(リサーチ会社):Market Research Future
◆発行日:2016年10月19日
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(印刷不可)USD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD8,350 ⇒換算¥943,550見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Research Future社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Introduction Small molecules are the organic compounds having low molecular weight which is approximately less than 900 Daltons. It includes lipids, monosaccharaides, secondary messengers, other natural products and metabolites, drugs and other xenobiotic. They are distinct from macromolecules such as proteins. In chemical biology, small molecule also includes metal ions and in this discipline small molecules may play the role of a chemical tool. Small molecules can have a variety of biological functions, such as cell signaling molecules, as drugs in medicine, as pesticides in farming, and in many other applications. These compounds can be natural or artificial; they may have a beneficial effect against a disease or they may be harmful. Most of the drugs are small molecules.
Globally, the market for small molecule API is gaining significant importance due to growing demand for newly developed small molecule APIs, and growing trend of contract manufacturing, among others. The total small molecule API market is expected to reach $279,687.1 million by 2027.
On the basis of types, biological API is by far the fastest growing segment of small molecule API and it is expected to reach $53,816.5 million in 2027.
Some other factors driving the small molecule API market are improving pharmaceutical industry in developing nations, growing corporate agreements, and such others.
Based on manufacturing methods, in-house manufacturing methods commands largest market share of small molecule API market and it is expected to grow at a CAGR of 6.6% for the period 2016 to 2027. On the other hand, contract manufacturing/CMO is expected to be the fastest growing manufacturing method for small molecule API market. Some of the factors driving the demand of CMO are growing trend of contract manufacturing, rising strategic alliances, low cost.
Some of the challenges faced by the market are stringent regulatory requirements, Austerity Measures, and high overhead cost.
Geographically, North America is one of the major revenue generator as well as producer of small molecule API due to high adoption rate. Also, growing healthcare and pharmaceutical industry coupled with improved R&D processes is boosting the growth of small molecule API market in Asian region.

Key Players
The leading market players in the global small molecule API market primarily include Albemarle Corporation (U.S.), Allergan plc (Ireland), AUROBINDO PHARMA (India), Cambrex Corporation (U.S.), Dr. Reddy’s Laboratories Ltd (India), GlaxoSmithKline plc (U.K.), Lonza (Switzerland), Merck Sharp & Dohme Corp. (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Pfizer Inc (U.S.), and others.  
Study Objectives of small molecule API Market Development and Demand Forecast to 2027 Market
 To provide insights about factors, influencing and affecting the market growth.
 To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
 To provide historical and forecast revenue of the market segments based on type, Application and Manufacturing Methods for Global Small molecules API market.
 To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
 To provide Economical factors that influences the Global Small Molecules API market.

Target Audience
• Pharmaceutical companies
• Research Laboratories
• Clinical Pathology Labs
• Hospitals & Clinics
• Component and Raw Material Suppliers
• Service Suppliers
• Potential Investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• The global market for small molecule API is expected to grow at a CAGR of 7.0% during the period 2016 to 2027 to reach $279,687.1 million by 2027.
• The Asian and Europe small molecule API market is expected to grow rapidly during 2016 to 2027; whereas, North America will remain the largest market in 2027.
• By application of small molecule API, oncology segment is expected to witness highest CAGR of 7.4% during the period 2016 to 2027.
• Based on the manufacturing methods, in-house manufacturing commands the largest market share of global small molecule API market; registered 60.1% share in 2015
• Teva pharmaceutical Industries Ltd., Lonza, Pfizer, Inc., are so far the leading market players for small molecule API market globally

Regional and Country Analysis of small molecule API Market Development and Demand Forecast to 2027 Market
As per the MRFR analysis, the Asia small molecule API market is poised to reach $XX billion in 2027, to grow at a CAGR of around 7.3% during the forecasted period. European market was valued at $ XX million in 2015, and expected to reach at $ 71,329.5 million by 2027. North America continues to be the leading region and valued at $48,337.9 million in 2015.
The reports also cover country level analysis:
• North America
o US
o Canada
• Europe
o Germany
o U.K.
o Italy
o Spain
o France
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Republic of Korea
o Australia
o Rest of Asia-Pacific

【レポートの目次】

1 1INTRODUCTION 11
1.1 DEFINITION 11
1.2 SCOPE OF STUDY 11
1.2.1 RESEARCH OBJECTIVE 11
1.2.2 ASSUMPTIONS & LIMITATIONS 12
1.2.2.1 ASSUMPTIONS 12
1.2.2.2 LIMITATIONS 12
1.3 MARKET STRUCTURE: 12
2 RESEARCH METHODOLOGY 13
2.1 RESEARCH PROCESS: 13
2.2 PRIMARY RESEARCH 14
2.3 SECONDARY RESEARCH: 14
3 MARKET DYNAMICS 15
3.1 DRIVERS 15
3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLECULES DRUGS 15
3.1.2 GROWING TREND OF OUTSOURCING 15
3.1.3 GROWING PHARMACEUTICAL INDUSTRY IN DEVELOPING NATIONS 16
3.2 RESTRAINTS 16
3.2.1 AUSTERITY MEASURES IN EUROPE 16
3.3 OPPORTUNITIES 16
3.4 MACROECONOMIC INDICATORS 17
4 MARKET FACTOR ANALYSIS 18
4.1 PORTERS FIVE FORCES MODEL 18
4.2 BARGAINING POWER OF SUPPLIERS 19
4.3 BARGAINING POWER OF BUYERS 19
4.4 THREAT OF NEW ENTRANTS 19
4.5 THREAT OF SUBSTITUTES 19
4.6 INTENSITY OF RIVALRY 19
5 GLOBAL SMALL MOLECULE API MARKET, BY TYPE 20
5.1 SYNTHETIC/CHEMICAL API 21
5.2 BIOLOGICAL API 22
6 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 24
6.1 CARDIOVASCULAR 26
6.2 ONCOLOGY 27
6.3 DIABETES 28
6.4 IMMUNOLOGICAL DISORDERS 29
7 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 30
7.1 IN-HOUSE MANUFACTURING 32
7.2 CONTRACT MANUFACTURING 33
7.2.1 INTRODUCTION 33
8 GLOBAL SMALL MOLECULE API MARKET, BY REGION 36
8.1 NORTH AMERICA 38
8.1.1 INTRODUCTION 39
8.2 EUROPE 45
8.2.1 INTRODUCTION 46
8.3 ASIA-PACIFIC 57
8.3.1 INTRODUCTION 58
8.4 MIDDLE EAST & AFRICA 71
8.4.1 INTRODUCTION 75
9 COMPETITIVE LANDSCAPE 76
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS 76
9.1.1 STRATEGIC PARTNERSHIP 77
9.1.2 MERGER & ACQUISITION 77
10 COMPANY PROFILE 79
10.1 ALBEMARLE CORPORATION 79
10.1.1 OVERVIEW 79
10.1.2 PRODUCT OVERVIEW 79
10.1.3 FINANCIALS 80
10.1.4 KEY DEVELOPMENTS 80
10.2 ALLERGAN PLC 81
10.2.1 OVERVIEW 81
10.2.2 PRODUCT OVERVIEW 81
10.2.3 FINANCIALS 82
10.2.4 KEY DEVELOPMENTS 82
10.3 AUROBINDO PHARMA 83
10.3.1 OVERVIEW 83
10.3.2 PRODUCT OVERVIEW 83
10.3.3 FINANCIALS 84
10.3.4 STRATEGY 84
10.3.5 KEY DEVELOPMENT 84
10.4 CAMBREX CORPORATION 85
10.4.1 OVERVIEW 85
10.4.2 PRODUCT OVERVIEW 85
10.4.3 FINANCIALS 86
10.4.4 KEY DEVELOPMENTS 86
10.5 DR. REDDY’S LABORATORIES LTD. 87
10.5.1 OVERVIEW 87
10.5.2 PRODUCT OVERVIEW 87
10.5.3 FINANCIALS 88
10.5.4 KEY DEVELOPMENTS 88
10.6 GLAXOSMITHKLINE PLC 89
10.6.1 OVERVIEW 89
10.6.2 PRODUCT OVERVIEW 89
10.6.3 FINANCIALS 90
10.6.4 STRATEGY 90
10.6.5 KEY DEVELOPMENTS 91
10.7 LONZA 91
10.7.1 OVERVIEW 91
10.7.2 PRODUCT OVERVIEW 91
10.7.3 FINANCIALS 92
10.7.4 STRATEGY 92
10.7.5 KEY DEVELOPMENTS 93
10.8 MERCK SHARP & DOHME CORP. 93
10.8.1 OVERVIEW 93
10.8.2 PRODUCT OVERVIEW 94
10.8.3 FINANCIAL 94
10.8.4 KEY DEVELOPMENTS 95
10.9 MYLAN N.V. 95
10.9.1 OVERVIEW 95
10.9.2 PRODUCT OVERVIEW 96
10.9.3 FINANCIALS 96
10.9.4 KEY DEVELOPMENTS 97
10.10 NOVARTIS AG 97
10.10.1 OVERVIEW 97
10.10.2 PRODUCT OVERVIEW 98
10.10.3 FINANCIALS 98
10.10.4 STRATEGY 98
10.10.5 DEVELOPMENTS 99
10.11 PFIZER INC. 99
10.11.1 OVERVIEW 99
10.11.2 PRODUCT OVERVIEW 100
10.11.3 FINANCIALS 100
10.11.4 KEY DEVELOPMENTS 101
10.12 SIEGFRIED AG 101
10.12.1 OVERVIEW 101
10.12.2 PRODUCT OVERVIEW 101
10.12.3 FINANCIALS 102
10.12.4 KEY DEVELOPMENTS 102
10.13 SUN PHARMACEUTICAL INDUSTRIES LTD. 103
10.13.1 OVERVIEW 103
10.13.2 PRODUCT OVERVIEW 103
10.13.3 FINANCIALS 104
10.13.4 KEY DEVELOPMENTS 104
10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD 105
10.14.1 OVERVIEW 105
10.14.2 PRODUCT OVERVIEW 105
10.14.3 FINANCIALS 106
10.14.4 STRATEGY 106
10.14.5 KEY DEVELOPMENTS 107

List of Tables
TABLE 1 Global Small Molecule API Market, By Type, 2014-2027 (USD million) 21
TABLE 2 Global Synthetic/chemical API Market, by region, 2014-2027 (USD million) 22
TABLE 3 Global Biological API Market, by region, 2014-2027 (USD million) 23
TABLE 4 Global Small Molecule API Market, By Application, 2014-2027 (USD million) 25
TABLE 5 Global Small Molecule API Market: Cardiovascular, by region, 2014-2027 (USD million) 26
TABLE 6 Global Small Molecule API Market: Oncology, by region, 2014-2027 (USD million) 27
TABLE 7 Global Small Molecule API Market: Diabetes, by region, 2014-2027 (USD million) 28
TABLE 8 Global Small Molecule API Market: Immunological disorders, by region, 2014-2027 (USD million) 29
TABLE 9 Global Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 31
TABLE 10 Global Small Molecule API Market, By In-House manufacturing, 2014-2027 (USD million) 32
TABLE 11 Global Small Molecule API Market, By Contract manufacturing, 2014-2027 (USD million) 33
TABLE 12 Global Small Molecule API Market, By Region, 2014-2027 (USD million) 37
TABLE 13 North America Small Molecule API Market, By Country, 2014-2027 (USD million) 38
TABLE 14 North America Small Molecule API Market, By Type, 2014-2027 (USD million) 39
TABLE 15 North America Small Molecule API Market, By Application, 2014-2027 (USD million) 40
TABLE 16 North America Small Molecule API Market, By Manufacturing Method, 2014-2027 (USD million) 41
TABLE 17 U.S. Small Molecule API Market, By Type, 2014-2027 (USD million) 42
TABLE 18 U.S. Small Molecule API Market, By Application, 2014-2027 (USD million) 43
TABLE 19 U.S. Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 43
TABLE 20 Canada Small Molecule API Market, By Type, 2014-2027 (USD million) 44
TABLE 21 Canada Small Molecule API Market, By Application, 2014-2027 (USD million) 44
TABLE 22 Canada Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 45
TABLE 23 Europe Small Molecule API Market, By Country, 2014-2027 (USD million) 46
TABLE 24 Europe Small Molecule API Market, By Type, 2014-2027 (USD million) 47
TABLE 25 Europe Small Molecule API Market, By Application, 2014-2027 (USD million) 48
TABLE 26 Europe Small Molecule API Market, By Manufacturing Method, 2014-2027 (USD million) 49
TABLE 27 Germany Small Molecule API Market, By Type, 2014-2027 (USD million) 50
TABLE 28 Germany Small Molecule API Market, By Application, 2014-2027 (USD million) 50
TABLE 29 Germany Small Molecule API Market, By Manufacturing Method, 2014-2027 (USD million) 51
TABLE 30 France Small Molecule API Market, By Type, 2014-2027 (USD million) 51
TABLE 31 France Small Molecule API Market, By Application, 2014-2027 (USD million) 52
TABLE 32 France Small Molecule API Market, By Manufacturing Method, 2014-2027 (USD million) 52
TABLE 33 U.K. Small Molecule API Market, By Type, 2014-2027 (USD million) 53
TABLE 34 U.K. Small Molecule API Market, By Application, 2014-2027 (USD million) 53
TABLE 35 U.K. Small Molecule API Market, By Manufacturing Method, 2014-2027 (USD million) 54
TABLE 36 Italy Small Molecule API Market, By Type, 2014-2027 (USD million) 54
TABLE 37 Italy Small Molecule API Market, By Application, 2014-2027 (USD million) 55
TABLE 38 Italy Small Molecule API Market, By Manufacturing Method, 2014-2027 (USD million) 55
TABLE 39 Spain Small Molecule API Market, By Type, 2014-2027 (USD million) 56
TABLE 40 Spain Small Molecule API Market, By Application, 2014-2027 (USD million) 56
TABLE 41 Spain Small Molecule API Market, By Manufacturing Method, 2014-2027 (USD million) 57
TABLE 42 Asia-Pacific Small Molecule API Market, By Country, 2014-2027 (USD million) 58
TABLE 43 Asia-Pacific Small Molecule API Market, By Type, 2014-2027 (USD million) 59
TABLE 44 Asia-Pacific Small Molecule API Market, By Application, 2014-2027 (USD million) 60
TABLE 45 Asia-Pacific Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 61
TABLE 46 Japan Small Molecule API Market, By Type, 2014-2027 (USD million) 62
TABLE 47 Japan Small Molecule API Market, By Application, 2014-2027 (USD million) 62
TABLE 48 Japan Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 63
TABLE 49 China Small Molecule API Market, By Type, 2014-2027 (USD million) 63
TABLE 50 China Small Molecule API Market, By Application, 2014-2027 (USD million) 64
TABLE 51 China Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 64
TABLE 52 India Small Molecule API Market, By Type, 2014-2027 (USD million) 65
TABLE 53 India Small Molecule API Market, By Application, 2014-2027 (USD million) 65
TABLE 54 India Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 66
TABLE 55 Republic of Korea Small Molecule API Market, By Type, 2014-2027 (USD million) 67
TABLE 56 Republic of Korea Small Molecule API Market, By Application, 2014-2027 (USD million) 67
TABLE 57 Republic of Korea Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 68
TABLE 58 Australia Small Molecule API Market, By Type, 2014-2027 (USD million) 69
TABLE 59 Australia Small Molecule API Market, By Application, 2014-2027 (USD million) 69
TABLE 60 Australia Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 70
TABLE 61 Middle East & Africa Small Molecule API Market, By Region, 2014-2027 (USD million) 71
TABLE 62 Middle East & Africa Small Molecule API Market, By Type, 2014-2027 (USD million) 72
TABLE 63 Middle East & Africa Small Molecule API Market, By Application, 2014-2027 (USD million) 73
TABLE 64 Middle East & Africa Small Molecule API Market, By Manufacturing Methods, 2014-2027 (USD million) 74


List Of Figures

FIGURE 1 RESEARCH PROCESS 14
FIGURE 2 PORTERS FIVE FORCES MODEL 19
FIGURE 3 GLOBAL SMALL MOLECULE API MARKET, BY TYPE 22
FIGURE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 26
FIGURE 5 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 32
FIGURE 6 CONTRACT MANUFACTURING ORGANIZATIONS: MARKET SHARE ANALYSIS (%) 35
FIGURE 7 GLOBAL SMALL MOLECULE API MARKET, BY REGION 38
FIGURE 8 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 39
FIGURE 9 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE 40
FIGURE 10 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION 41
FIGURE 11 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 42
FIGURE 12 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY (%) 46
FIGURE 13 EUROPE SMALL MOLECULE API MARKET, BY TYPE 48
FIGURE 14 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION 49
FIGURE 15 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 50
FIGURE 16 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY (%) 58
FIGURE 17 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE 60
FIGURE 18 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION 61
FIGURE 19 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 62
FIGURE 20 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 72
FIGURE 21 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE 73
FIGURE 22 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION 74
FIGURE 23 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 75
FIGURE 24 GLOBAL SMALL MOLECULE API MARKET: COMPANY SHARE ANALYSIS, 2015 (%) 77


【掲載企業】

Albemarle Corporation (U.S.), Allergan plc (Ireland), AUROBINDO PHARMA (India), Cambrex Corporation (U.S.), Dr. Reddy’s Laboratories Ltd (India), GlaxoSmithKline plc (U.K.), Lonza (Switzerland), Merck Sharp & Dohme Corp. (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Pfizer Inc (U.S.), and others.

【レポートのキーワード】

低分子API、医薬原体、合成/化学API、生物学的API

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 低分子API(医薬原体)の世界市場動向および予測:合成/化学API、生物学的API(Global Small Molecule API Market Development and Demand Research Report- Forecast to 2027 )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆